skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Leukemia remover assunto: Life Sciences & Biomedicine remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Leukemic Stem Cells: A Review
Leukemic Stem Cells: A Review
Material Type:
Artigo 		Adicionar ao Meu Espaço

Leukemic Stem Cells: A Review

O'Brien, J. A. ; Rizzieri, D. A.

Cancer investigation, 2013-05, Vol.31 (4), p.215-220 [Periódico revisado por pares]

New York, NY: Informa Healthcare

Texto completo disponível

Citações Citado por
2
Hematopoietic Engraftment and Survival in Adult Recipients of Umbilical-Cord Blood from Unrelated Donors
Hematopoietic Engraftment and Survival in Adult Recipients of Umbilical-Cord Blood from Unrelated Donors
Material Type:
Artigo 		Adicionar ao Meu Espaço

Hematopoietic Engraftment and Survival in Adult Recipients of Umbilical-Cord Blood from Unrelated Donors

Laughlin, Mary J ; Barker, Juliet ; Bambach, Barbara ; Koc, Omer N ; Rizzieri, David A ; Wagner, John E ; Gerson, Stanton L ; Lazarus, Hillard M ; Cairo, Mitchell ; Stevens, Cladd E ; Rubinstein, Pablo ; Kurtzberg, Joanne

The New England journal of medicine, 2001-06, Vol.344 (24), p.1815-1822 [Periódico revisado por pares]

Boston, MA: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
3
Results of a randomized phase 3 study of oral sapacitabine in elderly patients with newly diagnosed acute myeloid leukemia (SEAMLESS)
Results of a randomized phase 3 study of oral sapacitabine in elderly patients with newly diagnosed acute myeloid leukemia (SEAMLESS)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Results of a randomized phase 3 study of oral sapacitabine in elderly patients with newly diagnosed acute myeloid leukemia (SEAMLESS)

Kantarjian, Hagop M. ; Begna, Kebede H. ; Altman, Jessica K. ; Goldberg, Stuart L. ; Sekeres, Mikkael A. ; Strickland, Stephen A. ; Arellano, Martha L. ; Claxton, David F. ; Baer, Maria R. ; Gautier, Marc ; Berman, Ellin ; Seiter, Karen ; Solomon, Scott R. ; Schiller, Gary J. ; Luger, Selina M. ; Butrym, Aleksandra ; Gaidano, Gianluca ; Thomas, Xavier G. ; Montesinos, Pau ; Rizzieri, David A. ; Quick, Donald P. ; Venugopal, Parameswaran ; Gaur, Rakesh ; Maness, Lori J. ; Kadia, Tapan M. ; Ravandi, Farhad ; Buyse, Marc E. ; Chiao, Judy H.

Cancer, 2021-12, Vol.127 (23), p.4421-4431 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
4
Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm
Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm
Material Type:
Artigo 		Adicionar ao Meu Espaço

Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm

Pemmaraju, Naveen ; Lane, Andrew A ; Sweet, Kendra L ; Stein, Anthony S ; Vasu, Sumithira ; Blum, William ; Rizzieri, David A ; Wang, Eunice S ; Duvic, Madeleine ; Sloan, J. Mark ; Spence, Sharon ; Shemesh, Shay ; Brooks, Christopher L ; Balser, John ; Bergstein, Ivan ; Lancet, Jeffrey E ; Kantarjian, Hagop M ; Konopleva, Marina

The New England journal of medicine, 2019-04, Vol.380 (17), p.1628-1637 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
5
The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia, stem cells
The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia, stem cells
Material Type:
Artigo 		Adicionar ao Meu Espaço

The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia, stem cells

JORDAN, C. T ; UPCHURCH, D ; LUGER, S. M ; PHILLIPS, G. L ; SZILVASSY, S. J ; GUZMAN, M. L ; HOWARD, D. S ; PETTIGREW, A. L ; MEYERROSE, T ; ROSSI, R ; GRIMES, B ; RIZZIERI, D. A

Leukemia, 2000-10, Vol.14 (10), p.1777-1784 [Periódico revisado por pares]

London: Nature Publishing

Texto completo disponível

Citações Citado por
6
MK-0457, an Aurora kinase and BCR-ABL inhibitor, is active in patients with BCR-ABL T315I leukemia
MK-0457, an Aurora kinase and BCR-ABL inhibitor, is active in patients with BCR-ABL T315I leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

MK-0457, an Aurora kinase and BCR-ABL inhibitor, is active in patients with BCR-ABL T315I leukemia

Giles, F J ; Swords, R T ; Nagler, A ; Hochhaus, A ; Ottmann, O G ; Rizzieri, D A ; Talpaz, M ; Clark, J ; Watson, P ; Xiao, A ; Zhao, B ; Bergstrom, D ; Le Coutre, P D ; Freedman, S J ; Cortes, J E

Leukemia, 2013-01, Vol.27 (1), p.113-117 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
7
A phase 1 study of the pan‐bromodomain and extraterminal inhibitor mivebresib (ABBV‐075) alone or in combination with venetoclax in patients with relapsed/refractory acute myeloid leukemia
A phase 1 study of the pan‐bromodomain and extraterminal inhibitor mivebresib (ABBV‐075) alone or in combination with venetoclax in patients with relapsed/refractory acute myeloid leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase 1 study of the pan‐bromodomain and extraterminal inhibitor mivebresib (ABBV‐075) alone or in combination with venetoclax in patients with relapsed/refractory acute myeloid leukemia

Borthakur, Gautam ; Odenike, Olatoyosi ; Aldoss, Ibrahim ; Rizzieri, David A. ; Prebet, Thomas ; Chen, Chris ; Popovic, Relja ; Modi, Dimple A. ; Joshi, Rujuta H. ; Wolff, Johannes E. ; Jonas, Brian A.

Cancer, 2021-08, Vol.127 (16), p.2943-2953 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
8
Guadecitabine (SGI-110) in treatment-naive patients with acute myeloid leukaemia: phase 2 results from a multicentre, randomised, phase 1/2 trial
Guadecitabine (SGI-110) in treatment-naive patients with acute myeloid leukaemia: phase 2 results from a multicentre, randomised, phase 1/2 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Guadecitabine (SGI-110) in treatment-naive patients with acute myeloid leukaemia: phase 2 results from a multicentre, randomised, phase 1/2 trial

Kantarjian, Hagop M ; Roboz, Gail J ; Kropf, Patricia L ; Yee, Karen W L ; O'Connell, Casey L ; Tibes, Raoul ; Walsh, Katherine J ; Podoltsev, Nikolai A ; Griffiths, Elizabeth A ; Jabbour, Elias ; Garcia-Manero, Guillermo ; Rizzieri, David ; Stock, Wendy ; Savona, Michael R ; Rosenblat, Todd L ; Berdeja, Jesus G ; Ravandi, Farhad ; Rock, Edwin P ; Hao, Yong ; Azab, Mohammad ; Issa, Jean-Pierre J

The lancet oncology, 2017-10, Vol.18 (10), p.1317-1326 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
Cytogenetic risk determines outcomes after allogeneic transplantation in older patients with acute myeloid leukemia in their second complete remission: A Center for International Blood and Marrow Transplant Research cohort analysis
Cytogenetic risk determines outcomes after allogeneic transplantation in older patients with acute myeloid leukemia in their second complete remission: A Center for International Blood and Marrow Transplant Research cohort analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cytogenetic risk determines outcomes after allogeneic transplantation in older patients with acute myeloid leukemia in their second complete remission: A Center for International Blood and Marrow Transplant Research cohort analysis

Michelis, Fotios V. ; Gupta, Vikas ; Zhang, Mei‐Jie ; Wang, Hai‐Lin ; Aljurf, Mahmoud ; Bacher, Ulrike ; Beitinjaneh, Amer ; Chen, Yi‐Bin ; DeFilipp, Zachariah ; Gale, Robert Peter ; Kebriaei, Partow ; Kharfan‐Dabaja, Mohamed ; Lazarus, Hillard M. ; Nishihori, Taiga ; Olsson, Richard F. ; Oran, Betul ; Rashidi, Armin ; Rizzieri, David A. ; Tallman, Martin S. ; de Lima, Marcos ; Khoury, H. Jean ; Sandmaier, Brenda M. ; Weisdorf, Daniel ; Saber, Wael

Cancer, 2017-06, Vol.123 (11), p.2035-2042 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
10
Dose, schedule, safety, and efficacy of guadecitabine in relapsed or refractory acute myeloid leukemia
Dose, schedule, safety, and efficacy of guadecitabine in relapsed or refractory acute myeloid leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Dose, schedule, safety, and efficacy of guadecitabine in relapsed or refractory acute myeloid leukemia

Roboz, Gail J. ; Kantarjian, Hagop M. ; Yee, Karen W. L. ; Kropf, Patricia L. ; O'Connell, Casey L. ; Griffiths, Elizabeth A. ; Stock, Wendy ; Daver, Naval G. ; Jabbour, Elias ; Ritchie, Ellen K. ; Walsh, Katherine J. ; Rizzieri, David ; Lunin, Scott D. ; Curio, Tania ; Chung, Woonbok ; Hao, Yong ; Lowder, James N. ; Azab, Mohammad ; Issa, Jean‐Pierre J.

Cancer, 2018-01, Vol.124 (2), p.325-334 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (420)

Refinar Meus Resultados

Assunto 

  1. Oncology  (285)
  2. Humans  (269)
  3. Hematology  (202)
  4. Acute Myeloid Leukemia  (156)
  5. Stem Cells  (135)
  6. Chemotherapy  (130)
  7. Myeloid Leukemia  (124)
  8. Patients  (116)
  9. Female  (106)
  10. Male  (101)
  11. Transplantation  (99)
  12. Cancer  (90)
  13. Adult  (89)
  14. Middle Aged  (88)
  15. Stem Cell Transplantation  (84)
  16. Bone Marrow  (79)
  17. Hemopoiesis  (78)
  18. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de2003  (12)
  2. 2003Até2007  (29)
  3. 2008Até2012  (57)
  4. 2013Até2018  (145)
  5. Após 2018  (191)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.